Alterations of the Intestinal Barrier in Patients With Autism Spectrum Disorders and in Their First‐degree Relatives
The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Objectives Intestinal permeability (IPT) was investigated in patients with autism as well as in their first-degree relatives to investigate leaky gut hypothesis. Faecal calprotectin (FC) was also measured in patients with autism, either with or without gastrointestinal symptoms, and in their first-degree relatives. Patients and methods IPT results, assessed by means of the lactulose/mannitol test, were compared with adult and child controls and with FC values. Results A high percentage of abnormal IPT values were found among patients with autism (36.7%) and their relatives (21.2%) compared with normal subjects (4.8%). Patients with autism on a reported gluten-casein-free diet had significantly lower IPT values compared with those who were on an unrestricted diet and controls. Gastrointestinal symptoms were present in 46.7% of children with autism: constipation (45.5%), diarrhoea (34.1%), and others (alternating diarrhoea/constipation, abdominal pain, etc: 15.9%). FC was elevated in 24.4% of patients with autism and in 11.6% of their relatives; it was not, however, correlated with abnormal IPT values. Conclusions The results obtained support the leaky gut hypothesis and indicate that measuring IPT could help to identify a subgroup of patients with autism who could benefit from a gluten-free diet. The IPT alterations found in first-degree relatives suggest the presence of an intestinal (tight-junction linked) hereditary factor in the families of subjects with autism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Offspring from the poly (I:C) mouse model of MIA exhibit gastrointestinal changes that are also found in some humans with ASD155,156, including increased intestinal permeability and abnormal intestinal cytokine profiles157.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [156]
In the citing paper
“In the case of impaired BBB, which can be observed in certain (but not all) autistic subjects [37,254], LPS or SCFAs may cause brain inflammation and thus, further facilitate access to the brain for harmful substances, like heavy metals, that can accumulate there [228,246,255].”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [254]
In the citing paper
“Along with altered bowel habits, ASD has been associated with impaired intestinal barrier function (D'Eufemia et al., 1996; de Magistris et al., 2010; Fiorentino et al., 2016).”
From Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism (2017) · cites this paper as de Magistris et al., 2010
In the citing paper
“Many ASD children have also been shown to carry abnormalities in GI physiology, including: increased intestinal permeability [34,35], overall microbiota alterations [36,37,38,39,40], and gut infection with cresol-producing Clostridium difficile [39,41,42,43,44].”
From Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions (2019) · cites this paper as [35]
In the citing paper
“Intestinal dysbiosis is often associated, in the ASD population, with an alteration of the barrier of the intestinal mucosa with consequent increase of the intestinal permeability to exogenous substances of alimentary or bacterial origin, in some cases even neurotoxic [35].”
From Autism, Gastrointestinal Symptoms and Modulation of Gut Microbiota by Nutritional Interventions (2019) · cites this paper as [35]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
2 retracted
Gluten- and casein-free diets for autistic spectrum disorder
Millward, C., Ferriter, M., Calver, S. J., & Connell-Jones, G. G. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003498.pub3 · Cited by 274
RetractedGluten- and casein-free diets for autistic spectrum disorder
Ferriter, M., Calver, S. J., Connell-Jones, G. G., & Millward, C. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003498 · Cited by 27
RetractedLord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065 · cited 1×
“All of the children were administered the Autism Diagnostic Interview-Revised version (23), the Childhood Autism Rating Scales (24), and the Autism Diagnostic Observation Schedule-Generic (25) to document the diagnosis of autism.”
MethodToward objective classification of childhood autism: Childhood Autism Rating Scale (CARS)
Schopler, E., Reichler, R. J., DeVellis, R. F., & Daly, K. (1980) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02408436 · Cited by 2,432 · cited 1×
“All of the children were administered the Autism Diagnostic Interview-Revised version (23), the Childhood Autism Rating Scales (24), and the Autism Diagnostic Observation Schedule-Generic (25) to document the diagnosis of autism.”
MethodIntestinal permeability: an overview
Bjarnason, I., Macpherson, A., & Hollander, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90708-4 · Cited by 927 · cited 2×
“IPT, as measured by the urinary excretion of metabolically inert sugars after oral dosing, is a surrogate marker of mucosal integrity (16) and of gut barrier function.”
BackgroundBuie, T., Campbell, D. B., Fuchs, G. J., Furuta, G. T., Levy, J., VandeWater, J., Whitaker, A. H., Atkins, D., Bauman, M. L., Beaudet, A. L., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-1878c · Cited by 872 · cited 2×
“The precise role or frequency of increased paracellular permeability in children with ASD, as well as its correlation with the various clinical and behavioural aspects of ASD, remain unclear (5).”
BackgroundAssessment of the Neutrophil Dominating Protein Calprotectin in Feces: A Methodologic Study
RØseth, A. G., Fagerhol, M. K., Aadland, E., & Schjønsby, H. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529209011186 · Cited by 669 · cited 1×
“Normal values were estimated to be <100 mg/g stool (adult and children) on the basis of previous reports (28,29) and our own laboratory experience.”
BackgroundLammers, K. M., Lu, R., Brownley, J., Lu, B., Gerard, C., Thomas, K., Rallabhandi, P., Shea-Donohue, T., Tamiz, A., Alkan, S., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.023 · Cited by 540 · cited 1×
“The influence of environment (ie, ‘‘toxic’’ gluten) (35,51) on the intestinal barrier is also suggested.”
BackgroundIdentification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2
Tripathi, A., Lammers, K. M., Goldblum, S., Shea-Donohue, T., Netzel-Arnett, S., Buzza, M. S., Antalis, T. M., Vogel, S. N., Zhao, A., Yang, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906773106 · Cited by 443 · cited 1×
“The influence of environment (ie, ‘‘toxic’’ gluten) (35,51) on the intestinal barrier is also suggested.”
BackgroundTibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I., & Bjarnason, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.34755 · Cited by 441 · cited 1×
“Even though the possibility of day-to-day FC variations exists (48), our findings are in keeping with previous reports (49) and do not confirm those by Tibble et al (50).”
Result
Research works printed but not linked: 2
- Turck D, 2008, Walker's Pediatric Gastroenterologic Diseases: Pathophysiology, Diagnosis, Management
- 10.1097/00005176-200107000-00003 · doi:10.1097/00005176-200107000-00003 · Paper page
Cited by
Items 201–300 of 545
Gut Microbiota and Neurologic Diseases and Injuries
Patterson, T. T., & Grandhi, R. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-2385-4_6 · Cited by 46
Etiopathogenesis of autism spectrum disorders: Fitting the pieces of the puzzle together
Gentile, I., Zappulo, E., Militerni, R., Pascotto, A., Borgia, G., & Bravaccio, C. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.04.002 · Cited by 47
“Even the ‘‘leaky gut’’ theory of ASD [49,50], according to which the increased gut permeabilit y observed in some ASD patients could allow substances to enter the blood stream and create or exacerbate damage at central nervous system (CNS) level, as well as the gastrointestinal symptoms observed in a subset of patient…”
BackgroundSelf-citationPedersen, L., Parlar, S., Kvist, K., Whiteley, P., & Shattock, P. (2014) · Nutritional Neuroscience · doi:10.1179/1476830513y.0000000082 · Cited by 43
A review of candidate urinary biomarkers for autism spectrum disorder
Wang, L., Angley, M. T., Gerber, J. P., & Sorich, M. J. (2011) · Biomarkers · doi:10.3109/1354750x.2011.598564 · Cited by 43
“Inflammatory and immune changes may cause increased intestinal permeability (i.e. leaky gut) (D’Eufemia et al. 1996; de Magistris et al. 2010), which allow increased absorption of chemicals that are neuroactive (Reichelt et al. 1997).”
BackgroundGut Microbiota and Autism Spectrum Disorder: A Neuroinflammatory Mediated Mechanism of Pathogenesis?
Zarimeidani, F., Rahmati, R., Mostafavi, M., Darvishi, M., Khodadadi, S., Mohammadi, M., Shamlou, F., Bakhtiyari, S., & Alipourfard, I. (2024) · Inflammation · doi:10.1007/s10753-024-02061-y · Cited by 47
“Some reports show that ASD patients and their relatives may have higher calprotectin levels than control groups [41, 117].”
Antonucci, N., Cirillo, A., & Siniscalco, D. (2015) · Case Reports in Psychiatry · doi:10.1155/2015/325061 · Cited by 47
Scharf, M. W., Marques, T. M., Markgren, M., Löfvendahl, L., Brummer, R. J., & Wall, R. (2020) · Biomolecules · doi:10.3390/biom10050766 · Cited by 46
“Beyond the gut, increased intestinal permeability has been associated with diseases such as diabetes [5] and autism [6,7].”
BackgroundHaro, C., Villatoro, M., Vaquero, L. M., Pastor, J., Giménez, M. J., Ozuna, C. V., Sánchez‐León, S., García-Molina, M. D., Segura, V., Comino, I., et al. (2018) · Nutrients · doi:10.3390/nu10121964 · Cited by 47
“In the context of this study, the link between the intestine and the brain, the known Gut-Brain axis takes on a key role, since several studies postulate that an increase in intestinal permeability could allow gluten peptides to cross the intestinal barrier, enter to the bloodstream and ultimately cross the blood brai…”
BackgroundSerum zonulin and claudin-5 levels in children with obsessive–compulsive disorder
Işık, Ü., Avşar, P. A., Aktepe, E., Doğuç, D. K., Kılıç, F., & Büyükbayram, H. İ. (2020) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2020.1715474 · Cited by 46
“Some authors have evaluated these results as contributing to the symptoms of the psychiatric disorder [49], while others have suggested that the causality of changes may be unclear and that these results may be epiphenomena [50].”
BackgroundNettleton, J. E., Klančič, T., Schick, A., Choo, A. C., Cheng, N., Shearer, J., Borgland, S. L., Rho, J. M., & Reimer, R. A. (2021) · Microorganisms · doi:10.3390/microorganisms9091833 · Cited by 45
“Intestinal leakiness has been reported in nearly 40% of individuals with ASD [11], and is a likely contributor to the high incidence of gastrointestinal distress in this population [49].”
BackgroundSauer, A. K., Malijauskaite, S., Meleady, P., Boeckers, T. M., McGourty, K., & Grabrucker, A. M. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04052-w · Cited by 47
“Alterations such as “leaky gut” [20] and differences in gut microbiota composition in individuals with ASD have been reported [21–23].”
BackgroundBeyond the brain: A multi-system inflammatory subtype of autism spectrum disorder
Thom, R. P., Keary, C. J., Palumbo, M. L., Ravichandran, C. T., Mullett, J. E., Hazen, E. P., Neumeyer, A. M., & McDougle, C. J. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05280-6 · Cited by 46
Al-Harbi, N. O., Nadeem, A., Ahmad, S. F., AL-Ayadhi, L. Y., Al-Harbi, M. M., Sobeai, H. M. A., Ibrahim, K. E., & Bakheet, S. A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106555 · Cited by 44
Autism Spectrum Disorders: From Immunity to Behavior
Careaga, M., & Ashwood, P. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-62703-071-7_12 · Cited by 38
Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia
Jackson, J., Eaton, W., Cascella, N., Fasano, A., Santora, D., Sullivan, K., Feldman, S., Raley, H., McMahon, R. P., Carpenter, W. T., et al. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.023 · Cited by 38
Savelkoul, H. F. J. (2017) · Clinical Immunolgy & Immunotherapy · doi:10.24966/ciit-8844/100009 · Cited by 42
The role of microbiota in autism spectrum disorders
Campion, D., Ponzo, P., Alessandria, C., Saracco, G. M., & Balzola, F. A. (2018) · Minerva Gastroenterologica e Dietologica · doi:10.23736/s1121-421x.18.02493-5 · Cited by 41
“6% of the autistic patients, but there was no correlation between IPT and FC values.(45) Kushak et al.”
BackgroundGut microbiota metabolites in autistic children: An epigenetic perspective
Sabit, H., Tombuloğlu, H., Rehman, S., Almandil, N. B., Çevik, E., Abdel-Ghany, S. E., Rashwan, S., Abasiyanik, M. F., & Waye, M. M. Y. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06105 · Cited by 42
“Furthermore, dysbiosis of GMB have been reported in ASD animal models and also in children with pervasive developmental disorder-not otherwise specified (PDD-NOS) [18, 57, 58].”
BackgroundClinical practice: Coeliac disease
Kneepkens, C. M. F., & Blomberg, B. M. E. V. (2012) · European Journal of Pediatrics · doi:10.1007/s00431-012-1714-8 · Cited by 40
“For instance, there is much debate about a possible role for gluten sensitivity in children with autism spectrum disorders [22].”
Maladaptive Behavior and Gastrointestinal Disorders in Children with Autism Spectrum Disorder
Pusponegoro, H. D., Ismael, S., Sastroasmoro, S., Firmansyah, A., & Vandenplas, Y. (2015) · Pediatric Gastroenterology, Hepatology & Nutrition · doi:10.5223/pghn.2015.18.4.230 · Cited by 38
Celiac Disease and Nonceliac Gluten Sensitivity
Watkins, R. D., & Zawahir, S. (2017) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2017.01.013 · Cited by 42
Wang, L., Yu, Y.-M., Zhang, Y.-Q., Zhang, J., Lu, N., & Liu, N. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1039-2 · Cited by 38
The Neuro‐Immune Axis: Prospect for Novel Treatments for Mental Disorders
Kraneveld, A. D., de Theije, C. G. M., van Heesch, F., Borre, Y., de Kivit, S., Olivier, B., Korte, M., & Garssen, J. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12154 · Cited by 37
Autism and EMF? Plausibility of a pathophysiological link – Part I
Herbert, M. R., & Sage, C. (2013) · Pathophysiology · doi:10.1016/j.pathophys.2013.08.001 · Cited by 42
Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story
Carbone, E., Manduca, A., Cacchione, C., Vicari, S., & Trezza, V. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.009 · Cited by 42
Józefczuk, J., Konopka, E., Bierła, J. B., Trojanowska, I., Sowińska, A., Czarnecki, R., Sobol, L., Józefczuk, P., Surdy, W., & Cukrowská, B. (2017) · Journal of Medicinal Food · doi:10.1089/jmf.2017.0069 · Cited by 37
“13,14 In addition, patients with autism on gluten and casein free diet (GCFD) had significantly improved the gut barrier compared with those who were on an unrestricted diet and controls.”
Association between increased intestinal permeability and disease: A systematic review
Leech, B., Schloss, J. M., & Steel, A. (2018) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2018.08.003 · Cited by 42
Autism and Migraine: An Unexplored Association?
Vetri, L. (2020) · Brain Sciences · doi:10.3390/brainsci10090615 · Cited by 42
“The dysbiosis is associated in patients with ASD with an alteration of the intestinal mucosa barrier with a consequent increased permeability to exogenous molecules [89].”
BackgroundRincel, M., Olier, M., Minni, A., de Oliveira, C. M., Matime, Y., Gaultier, E., Grit, I., Helbling, J., Costa, A., Lépinay, A. L., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05252-w · Cited by 36
Wong, G. C., Montgomery, J. M., & Taylor, M. W. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.autismspectrumdisorders.2021 · Cited by 47
A review of gluten- and casein-free diets for treatment of autism: 2005–2015
Elder, J. H., Kreider, C. M., Schaefer, N., & deLaosa, M. (2015) · Nutrition and Dietary Supplements · doi:10.2147/nds.s74718 · Cited by 50
Dietary interventions that reduce mTOR activity rescue autistic-like behavioral deficits in mice
Wu, J., de Theije, C. G. M., da Silva, S. L., Abbring, S., van der Horst, H. J., Broersen, L. M., Willemsen, L. E. M., Kas, M. J., Garssen, J., & Kraneveld, A. D. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.016 · Cited by 36
“(de Magistris et al., 2010).”
Serra, D., Henriques, J. F., Sousa, F. J., Laranjo, M., Resende, R., Ferreira‐Marques, M., de Freitas, V. A. P., Silva, G., Peça, J., Dinis, T. C. P., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169259 · Cited by 37
“interplay between the gut or gut microbiota and the brain has recently gained much attention in the context of ASD on the basis of several pieces of evidence, namely: (i) children with ASD often report gastrointestinal symptoms (GI), such as diarrhea, constipation, and abdominal pain, and GI symptoms seem to be strong…”
BackgroundMall, J. G., Löfvendahl, L., Lindqvist, C. M., Brummer, R. J., Keita, Å. V., & Schoultz, I. (2018) · Scientific Reports · doi:10.1038/s41598-018-31492-5 · Cited by 39
Ranieri, A., Mennitti, C., Falcone, N., La Monica, I., Di Iorio, M. R., Tripodi, L., Gentile, A., Vitale, M., Pero, R., Pastore, L., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1238797 · Cited by 32
Association Between Celiac Disease and Autism Spectrum Disorder: A Systematic Review
Quan, J., Panaccione, N., Jeong, J., Underwood, F. E., Coward, S., Windsor, J. W., Ronksley, P. E., Gidrewicz, D., deBruyn, J., Turner, J. M., et al. (2021) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003051 · Cited by 32
“Blood levels of opioid peptides may also be increased through altered intestinal permeability, which is a manifestation of celiac disease (19,20).”
BackgroundOverview and Introduction to Autism Spectrum Disorder (ASD)
Al-Dewik, N. I. E., Al‐Jurf, R., Styles, M., Tahtamouni, S., Al‐Sharshani, D., Alsharshani, M., Ahmad, A. I., Khattab, A., Rifai, H. A., & Qoronfleh, M. W. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_1 · Cited by 45
Majhi, S., Kumar, S., & Singh, L. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220428134802 · Cited by 41
Intestinal permeability and nutritional status in developmental disorders.
Souza, N. C., Mendonça, J. N., Portari, G. V., Jordão, A. A., Marchini, J. S., & Chiarello, P. G. (2012) · PubMed · Cited by 40
Serra, D., Almeida, L. M., & Dinis, T. C. P. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.010 · Cited by 33
The role of the gut microbiome in mediating neurotoxic outcomes to PCB exposure
Rude, K. M., Keogh, C. E., & Gareau, M. G. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.010 · Cited by 34
Moradi, K., Ashraf‐Ganjouei, A., Tavolinejad, H., Bagheri, S., & Akhondzadeh, S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110091 · Cited by 34
Piras, C., Mussap, M., Noto, A., GIACOMO, A. D., Cristofori, F., Spada, M., Fanos, V., Atzori, L., & Francavilla, R. (2022) · Metabolites · doi:10.3390/metabo12020104 · Cited by 37
“For the lactulose:mannitol test, we followed the procedure previously reported elsewhere [73].”
MethodSelf-citationChiappori, F., Cupaioli, F. A., Consiglio, A., Nanni, N. D., Mosca, E., Licciulli, F., & Mezzelani, A. (2022) · Nutrients · doi:10.3390/nu14071340 · Cited by 36
“This allows macromolecules, such as toxins and food antigens, to enter the bloodstream and trigger food intolerance and allergies, as described in a subset of children with ASD [99].”
BackgroundPrenatal Zinc Deficient Mice as a Model for Autism Spectrum Disorders
Sauer, A. K., Hagmeyer, S., & Grabrucker, A. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116082 · Cited by 35
“Among these, problems linked to altered intestinal barrier function are frequently reported [92,93].”
BackgroundMucosal Immunity and the Gut-Microbiota-Brain-Axis in Neuroimmune Disease
Sterling, K. G., Dodd, G. K., Alhamdi, S., Asimenios, P. G., Dagda, R. K., Meirleir, K. L. D., Hudig, D., & Lombardi, V. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113328 · Cited by 36
Exploring Dietary Interventions in Autism Spectrum Disorder
Pérez-Cabral, I. D., Bernal-Mercado, A. T., Islas-Rubio, A. R., Suárez-Jiménez, G. M., Robles-García, M. Á., Puebla-Duarte, A. L., & Del‐Toro‐Sánchez, C. L. (2024) · Foods · doi:10.3390/foods13183010 · Cited by 44
“…interest in the morphology of the GI structure in children with ASD, which can present a high intestinal permeability (nearly 40% in comparison to the neurotypical public, presenting only 5%), high levels of pro-inflammatory lymphocytes, or even colonic lesions due to epithelial damage [67,68].”
BackgroundThe role of IgG hypersensitivity in the pathogenesis and therapy of depressive disorders
Karakuła‐Juchnowicz, H., Szachta, P., Opolska, A., Morylowska-Topolska, J., Gałęcka, M., Juchnowicz, D., Krukow, P., & Lasik, Z. (2014) · Nutritional Neuroscience · doi:10.1179/1476830514y.0000000158 · Cited by 33
The Gut-Brain Axis in Autism Spectrum Disorder: A Focus on the Metalloproteases ADAM10 and ADAM17
Zheng, Y., Verhoeff, T. A., Perez‐Pardo, P., Garssen, J., & Kraneveld, A. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010118 · Cited by 39
Studying Autism Using Untargeted Metabolomics in Newborn Screening Samples
Courraud, J., Ernst, M., Laursen, S. S., HOUGAARD, D. M., & Cohen, A. S. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01787-2 · Cited by 34
Gonzales, J. A., Marchix, J., Aymeric, L., Berre‐Scoul, C. L., Zoppi, J., Bordron, P., Burel, M., Davidovic, L., Richard, J., Gaman, A., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9081723 · Cited by 37
“In clinical studies, no difference [13] or increased intestinal permeability have been shown in ASD children in comparison to controls [11,12], while the colonic permeability has not been specifically addressed so far.”
BackgroundEarly Influences of Microbiota on White Matter Development in Germ-Free Piglets
Ahmed, S. A., Travis, S. D., Díaz-Bahamonde, F. V., Porter, D. D. L., Henry, S. N., Mykins, J., Ravipati, A., Booker, A., Ju, J., Ding, H., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.807170 · Cited by 32
“For example, intestinal complications (de Magistris et al., 2010), changes in microbial composition (Louis, 2012), and food allergies (de Theije et al., 2014) have been documented in pediatric patients with autism spectrum disorders (ASD).”
BackgroundTobiasova, Z., van der Lingen, K. H. B., Scahill, L., Leckman, J. F., Zhang, Y., Chae, W., McCracken, J. T., McDougle, C. J., Vitiello, B., Tierney, E., et al. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0134 · Cited by 29
“In subjects with autism, altered permeability of the intestinal barrier has been reported (D’eufemia et al. 1996; De Magistris et al. 2010).”
BackgroundFrom “Leaky Gut” to Impaired Glia-Neuron Communication in Depression
Rudzki, L., & Maes, M. H. J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_9 · Cited by 33
David, M. M., Tataru, C. A., Daniels, J., Schwartz, J. N., Keating, J., Hampton‐Marcell, J., Gottel, N., Gilbert, J. A., & Wall, D. P. (2021) · mSystems · doi:10.1128/msystems.00193-20 · Cited by 41
Neuropeptides in the microbiota-brain axis and feeding behavior in autism spectrum disorder
Fetissov, S. O., Averina, O. V., & Даниленко, В. Н. (2018) · Nutrition · doi:10.1016/j.nut.2018.10.030 · Cited by 34
Żebrowska-Różańska, P., Łaczmańska, I., & Łaczmański, Ł. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.630052 · Cited by 36
“…those derived from the diet, and neurotoxic peptides of bacterial origin Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 (de Magistris et al., 2010; Gonzalez et al., 2011) or the lipopolysaccharide (LPS) which elicits a pro-inflammatory response (Jyonouchi et al., 2002).”
BackgroundTorres, E. B., Isenhower, R. W., Yanovich, P., Rehrig, G., Stigler, K. A., Nürnberger, J. I., & José, J. V. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00059.2013 · Cited by 30
Recent advances in understanding the roles of the enteric nervous system
Chanpong, A., Borrelli, O., & Thapar, N. (2022) · Faculty Reviews · doi:10.12703/r/11-7 · Cited by 34
Ghaderi, F., Sotoodehnejadnematalahi, F., Hajebrahimi, Z., Fateh, A., & Siadat, S. D. (2022) · Scientific Reports · doi:10.1038/s41598-022-13840-8 · Cited by 36
Babinská, K., Tomova, A., Celušáková, H., Babková, J., Repiská, G., Kubranská, A., Filcikova, D., Siklenkova, L., & Ostatníková, D. (2017) · Physiological Research · doi:10.33549/physiolres.933801 · Cited by 33
“In the study of De Magistris et al. (2010) pathological high mean value of FC was found in individuals with ASD indicating a mild degree of intestinal inflammation, while in our study the median concentration was in the normal range.”
BackgroundMicrobiota Gut–Brain Axis and Autism Spectrum Disorder: Mechanisms and Therapeutic Perspectives
Petropoulos, A., Stavropoulou, E., Tsigalou, C., & Bezirtzoglou, E. (2025) · Nutrients · doi:10.3390/nu17182984 · Cited by 44
“Numerous studies have compared the gut microbiota of individuals with ASD to that of neurotypical controls [43].”
Common Genetic Variants Link the Abnormalities in the Gut-Brain Axis in Prematurity and Autism
Sajdel-Sulkowska, E. M., Makowska‐Zubrycka, M., Czarzasta, K., Kasarełło, K., Aggarwal, V., Biały, M., Szczepanska‐Sadowska, E. K., & Cudnoch‐Jędrzejewska, A. (2018) · The Cerebellum · doi:10.1007/s12311-018-0970-1 · Cited by 28
Khan, Z. U. N., Chand, P., Majid, H., Ahmed, S., Khan, A. H., Jamil, A., Ejaz, S., Wasim, A., Khan, K. A., & Jafri, L. (2022) · BMC Neurology · doi:10.1186/s12883-022-02630-4 · Cited by 32
Golomb, B. A. (2012) · Nature Precedings · doi:10.1038/npre.2012.6847.1 · Cited by 27
de Theije, C. G. M., van den Elsen, L. W. J., Willemsen, L. E. M., Milosevic, V., Korte-Bouws, G. A. H., da Silva, S. L., Broersen, L. M., Korte, S. M., Olivier, B., Garssen, J., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.001 · Cited by 29
Coeliac disease and noncoeliac wheat or gluten sensitivity
Rej, A., Aziz, I., & Sanders, D. S. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13120 · Cited by 28
A metaproteomic-based gut microbiota profiling in children affected by autism spectrum disorders
Mortera, S. L., Vernocchi, P., Basadonne, I., Zandonà, A., Chierici, M., Durighello, M., Marzano, V., Gardini, S., Gasbarrini, A., Urbani, A., et al. (2021) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104407 · Cited by 28
Possible use of Trichuris suis ova in autism spectrum disorders therapy
Siniscalco, D., & Antonucci, N. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.03.024 · Cited by 25
“It has been reported an increased intestinal permeability (leaky gut) in a large percentage of not-celiac autistic subjects that was partially corrected by the implementation of a gluten-free diet [56].”
BackgroundPenn, A. H., Carver, L. J., Herbert, C., Lai, T. S., McIntire, M. J., Howard, J. T., Taylor, S. F., Schmid‐Schönbein, G. W., & Dobkins, K. R. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000907 · Cited by 45
“Regardless of the extent to which the risk for developing ASD is because of genes or environment, many studies have now shown that even those highrisk infants who do not develop ASD show abnormalities compared with low-risk control children (from families without ASD history) (see (19) for review and (20) for evidence…”
BackgroundResultSex differences in zonulin in affective disorders and associations with current mood symptoms
Maget, A., Dalkner, N., Hamm, C., Bengesser, S., Fellendorf, F. T., Platzer, M., Queissner, R., Birner, A., Lenger, M., Mörkl, S., et al. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.07.021 · Cited by 32
Gu, Y., Han, Y., Ren, S., Zhang, B., Zhao, Y., Wang, X., Zhang, S., & Qin, J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113580 · Cited by 27
Mack, D. L., Guan, X., Wagoner, A. L., Walker, S. J., & Childers, M. K. (2014) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000141 · Cited by 25
Crosstalk Between the Microbiome and Gestational Immunity in Autism-Related Disorders
Paysour, M. J., Bolte, A. C., & Lukens, J. R. (2019) · DNA and Cell Biology · doi:10.1089/dna.2019.4653 · Cited by 26
“…(GI) comorbidities, including constipation, diarrhea, gastroesophageal reflux disease, increased gut permeability (also called ‘‘leaky gut’’), GI inflammatory disease, and gut dysbiosis (Parracho et al., 2005; Buie et al., 2010; de Magistris et al., 2010; Finegold et al., 2010; Adams et al., 2011).”
BackgroundAutism and Gut–Brain Axis: Role of Probiotics
Chidambaram, S. B., Tuladhar, S., Bhat, A., Mahalakshmi, A. M., Ray, B., Essa, M. M., Bishir, M., Bolla, S. R., Nanjaiah, N. D., Guillemin, G. J., et al. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_21 · Cited by 31
Karagözlü, S., Dalgıç, B., & İşeri, E. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-04966-1 · Cited by 30
Rowshan, N., Anjomshoa, M., Farahzad, A., Bijad, E., & Amini-Khoei, H. (2024) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10329 · Cited by 22
“Clinical investigations have shown changes in intestinal integrity and permeability in patients with autism (de Magistris et al., 2013; de Magistris et al., 2010; D ’ Eufemia et al., 1996; Liu et al., 2017).”
BackgroundSimone, R. D., Butera, A., Armida, M., Pèzzola, A., Boirivant, M., Potenza, R. L., & Ricceri, L. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.03.041 · Cited by 22
Potential of Salivary Biomarkers in Autism Research: A Systematic Review
Janšáková, K., Kyselicová, K., Ostatníková, D., & Repiská, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910873 · Cited by 28
Tonkaz, G. Y., ESİN, İ. S., Turan, B., Uslu, H., & Dursun, O. B. (2022) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-022-05540-z · Cited by 27
“Again, in another study, the granulocyte-derived protein calprotectin was found to be elevated in feces in the ASD group (de Magistris et al., 2010).”
BackgroundResultBilgiç, A., Ferahkaya, H., Karagöz, H., Kılınç, İ., & Energin, V. M. (2023) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2023.2168055 · Cited by 25
“Magistris and colleagues assessed intestinal permeability in ASD by means of the lactulose/mannitol test and detected abnormal values in children with ASD compared to their typically developing peers [17].”
Bottoms up: the role of gut microbiota in brain health
Radisavljevic, N., Cirstea, M., & Brett Finlay, B. (2019) · Environmental Microbiology · doi:10.1111/1462-2920.14506 · Cited by 22
Cupertino, M. D. C., Resende, M. B., Veloso, I. D. F., de Carvalho, C. A., Duarte, V. F., & Ramos, G. A. (2019) · ABCS Health Sciences · doi:10.7322/abcshs.v44i2.1167 · Cited by 55
Retuerto, M., Al-Shakhshir, H., Herrada, J., McCormick, T. S., & Ghannoum, M. A. (2024) · Nutrients · doi:10.3390/nu16173004 · Cited by 27
“[24], an observation that has also been reported by D’Eufemia et al. [20].”
BackgroundFasano, A., & Hill, I. D. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.05.038 · Cited by 23
Gastrointestinal disease in children with autism spectrum disorders: Etiology or consequence?
Krigsman, A., & Walker, S. J. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i9.605 · Cited by 26
Kittana, M., Ahmadani, A., Al-Marzooq, F. I., & Attlee, A. (2021) · Nutrients · doi:10.3390/nu13113818 · Cited by 25
“The depletion of butyrate-producing bacteria and enrichment of mucin-degraders can be linked to the observed abnormal intestinal permeability reported in individuals with autism [96].”
BackgroundAutism and associated disorders: cannabis as a potential therapy
Babayeva, M., Assefa, H., Basu, P., & Loewy, Z. G. (2022) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1401001 · Cited by 35
“PEA with its intestinal anti-inflammatory characteristics is a point of interest for autism since part of the autistic chronic inflammatory state is mediated via the gastrointestinal associated immune system [83,106,107].”
BackgroundAndersen‐Civil, A. I. S., Sawale, R. A., & Vanwalleghem, G. C. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.001 · Cited by 28
“Similarly, decreased intestinal permeability in ASD is demonstrated using the lactulose:mannitol test (D’Eufemia et al., 1996; de Magistris et al., 2010).”
Maternal Antibody and ASD: Clinical Data and Animal Models
Gata-Garcia, A., & Diamond, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01129 · Cited by 24
Autism and Our Intestinal Microbiota
Reddy, B. L., & Saier, M. H. (2015) · Microbial Physiology · doi:10.1159/000375303 · Cited by 24
Gut-immune-brain dysfunction in Autism: Importance of sex
Kopec, A. M., Fiorentino, M. R., & Bilbo, S. D. (2018) · Brain Research · doi:10.1016/j.brainres.2018.01.009 · Cited by 23
The Gut-Microbiota-Brain Axis in Autism Spectrum Disorder
Wong, G. C., Montgomery, J. M., & Taylor, M. W. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.autismspectrumdisorders.2021.gutmicrobiota · Cited by 33
Rostami‐Nejad, M., Karkhane, M., Marzban, A., Mojarad, E. N., & Rostami, K. (2012) · Gastroenterology and hepatology from bed to bench. · Cited by 20
A Computational Framework for Studying Gut-Brain Axis in Autism Spectrum Disorder
Mohammad, F. K., Palukuri, M. V., Shivakumar, S., Rengaswamy, R., & Sahoo, S. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.760753 · Cited by 25
“…for both the gut and the brain, with the former allowing high exchanges of oxidative stress-related toxins across membranes because of increased permeability observed in autistic conditions (de Magistris et al., 2010; Fiorentino et al., 2016), and the latter corresponding to low toxin exchange.”
BackgroundMazahery, H., Conlon, C. A., Beck, K. L., Kruger, M. C., Stonehouse, W., Camargo, C. A., Meyer, B. J., Tsang, B., Mugridge, O., & von Hurst, P. R. (2016) · Trials · doi:10.1186/s13063-016-1428-8 · Cited by 24
“Gastrointestinal problems may relate to abnormal gut flora [45], decreased activity of digestive enzymes [46] or increased intestinal permeability [47].”
Parkinson’s disease: Are gut microbes involved?
Bhattarai, Y., & Kashyap, P. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00058.2020 · Cited by 21
Gastrointestinal manifestations and their relation to faecal calprotectin in children with autism
Azouz, H. G., Zakaria, N. H., Khalil, A. F., Naguib, S. M., & Khalil, M. (2021) · Gastroenterology Review · doi:10.5114/pg.2021.111420 · Cited by 27
“6% of their relatives, and the mean pathological value of FC found in these patients indicated a mild degree of inflammation of the bowel [15].”
BackgroundRelationship between Excreted Uremic Toxins and Degree of Disorder of Children with ASD
Osredkar, J., Gantar, B. Ž. B., Finderle, P., Bobrowska‐Korczak, B., Gątarek, P., Rosiak, A., Giebułtowicz, J., Vrhovšek, M. J., & Kałużna‐Czaplińska, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087078 · Cited by 20
Cai, Y., Deng, W., Yang, Q., Pan, G., Liang, Z., Yang, X., Li, S., & Xiao, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111783 · Cited by 22
Metadata
- Authors
- de Magistris, L., Familiari, V., Pascotto, A., Sapone, A., Frolli, A., Iardino, P., Carteni, M., De Rosa, M., Francavilla, R., Riegler, G., Militerni, R., & Bravaccio, C.
- Affiliations
- Department Magrassi‐Lanzara Gastroenterology Italy
- Department of Psychiatry, Neuropsychiatry, Dermatovenereology Italy
- University of Campania "Luigi Vanvitelli" (IT)
- Department of Experimental Medicine Italy
- University of Bari Aldo Moro (IT)
- Federico II University Hospital (IT)
- Corresponding author
- de Magistris, Laura
- Familiari, Valeria
- Sapone, Anna
- Riegler, Gabriele
- Venue
- Journal of Pediatric Gastroenterology and Nutrition
- Publisher
- Wiley
- Published
- 2010-10
- Volume
- 51
- Issue
- 4
- Pages
- 418-424
- ISSN
- 0277-2116 (ISSN-L)
- 1536-4801
- OpenAlex
- W2046831320
- Cited by
- 546
- References
- 55
- Citations by year
- 2026: 18 · 2025: 33 · 2024: 31 · 2023: 31 · 2022: 36 · 2021: 58 · 2020: 48 · 2019: 43 · 2018: 49 · 2017: 28 · 2016: 36 · 2015: 30 · 2014: 28 · 2013: 35 · 2012: 27
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Gastroenterology and Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, intestinal permeability, fecal calprotectin, lactulose/mannitol test, gluten-free diet, gastrointestinal symptoms, constipation, diarrhea, first-degree relatives, tight junctions
- MeSH terms
- Analysis of Variance, Child, Child Development Disorders, Pervasive, Constipation, Diarrhea, Enzyme-Linked Immunosorbent Assay, Family, Feces, Female, Humans, Inflammation, Intestinal Diseases, Intestinal Mucosa, Italy, Male, Permeability, Abdominal Pain, Comorbidity, Leukocyte L1 Antigen Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.